{"id":3902,"date":"2018-02-12T16:55:31","date_gmt":"2018-02-12T21:55:31","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3902"},"modified":"2018-02-12T16:55:31","modified_gmt":"2018-02-12T21:55:31","slug":"secondaries-announced-2-12-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-2-12-18\/","title":{"rendered":"Secondaries Announced 2.12.18"},"content":{"rendered":"<h4><strong>IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n<p>If having\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/ipo-boutique-announces-new-secondary-alert-service\/#sthash.HnSepMmy.dpbs\" target=\"_blank\"><strong>real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,<a style=\"border-bottom-width: 1px; border-bottom-style: solid; border-bottom-color: #333333; color: #333333; text-decoration: none;\" href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">\u00a0inquire about a subscription today!<\/a><\/p>\n<p>Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n<p>Company: Daseke, Inc.<br \/>\nSymbol: DSKE<br \/>\nPrice: Last Trade $12.98<br \/>\nTrade Date: 2\/15<br \/>\nShares: 7.5 million<br \/>\nUnderwriter(s): Cowen, Stifel<br \/>\nCo-Manager(s): Craig-Hallum Capital Group, Northland Capital<br \/>\nDescription: They are a leading provider and consolidator of transportation and logistics solutions focused exclusively on flatbed and specialized freight in North America.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Helios and Matheson Analytics Inc.<br \/>\nSymbol: HMNY<br \/>\nPrice: Last Trade $7.99<br \/>\nTrade Date: 2\/13<br \/>\nShares: 13.1 million ($105 million cash raise)<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s): Canaccord Genuity<br \/>\nCo-Manager(s): Maxim Group<br \/>\nDescription: They are a provider of information technology services and solutions, offering a range of technology platforms focusing on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Pacific Biosciences of California<br \/>\nSymbol: PACB<br \/>\nPrice: Last Trade $2.54<br \/>\nTrade Date: 2\/13<br \/>\nShares: 12.24 million ($30 million cash raise)<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s): Cantor Fitzgerald<br \/>\nDescription: Pacific Biosciences offers sequencing systems to help scientists resolve genetically complex problems.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Affimed, Inc.<br \/>\nSymbol: AFMD<br \/>\nPrice: Last Trade $2.45<br \/>\nTrade Date: 2\/13<br \/>\nShares: 9.2 million<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s): Jefferies, Wells Fargo Securities<br \/>\nDescription: Affimed engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity.<br \/>\nRating =<strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Catalyst Biosciences, Inc.<br \/>\nSymbol: CBIO<br \/>\nPrice: Last Trade $35.60<br \/>\nTrade Date: 2\/13<br \/>\nShares: 2.2 million ($75 million cash raise)<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s): JonesTrading, Ladenburg Thalmann<br \/>\nCo-Manager(s): LifeSci Capital<br \/>\nDescription: Catalyst is a clinical-stage biopharmaceutical company developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-3902","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3902"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3902\/revisions"}],"predecessor-version":[{"id":3903,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3902\/revisions\/3903"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}